Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on ...

Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...

Absci Corporation (NASDAQ:ABSI) is a leading biotechnology company revolutionizing the drug discovery and development process through the integration of artificial intelligence (AI) and synthetic ...

a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases, today announced the successful closing of a $67 million Series A ...

Dewpoint will present the following two posters: About Dewpoint Therapeutics Dewpoint is the leading biotech company in the application of biomolecular condensate biology towards the development ...

NEW YORK, March 26, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company committed to the development and commercialization of best-in-class ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...